• 专利附录
  • 专利说明
  • 权利要求
  • 类似技术
  • 同族专利
  • 引用文献
  • 法律状态
  • 优先权
    • 专利摘要:
    The present invention provides compositions and pharmaceutical formulations of plasma-derived factor H. Further provided are methods of making factor H compositions and formulations, as well as methods of treating diseases associated with factor H dysfunction.
    公开号:AT514675A3
    申请号:T50852/2014
    申请日:2010-07-23
    公开日:2018-05-15
    发明作者:
    申请人:Baxalta Inc；Baxalta GmbH；
    IPC主号:
    专利说明:

    852/2014 07/23/2010 (51) Int. Cl .: A61K38 / 17
    C07K 1/14 C07K 14/47 (2006.01) (2006.01) (2006.01) (62) (30)
    May 15, 2018
    Eliminated from A 9249/2010
    Priority:
    07/23/2009 US 61 / 227,968 claimed.
    (56) References: US 2008318841 A1 WO 2007038995 A1 (71) Patent applicants:
    Baxalta Incorporated 60015 Bannockburn (US) Baxalta GmbH
    8152 Glattpark (Opfikon) (CH)
    AT 514675 A3 2018-05-15 (54) PRODUCTION OF FACTOR H (FH) AND FH DERIVATIVES FROM PLASMA (57) The present invention provides compositions and pharmaceutical formulations of factor H obtained from plasma. Methods for making factor H compositions and formulations, as well as methods for treating diseases associated with factor H dysfunction, are also provided.
    DVR 0078018
    Search report for A 50852/2014
    Classification of the subject of the application according to IPC:
    A61K 38/17 (2006.01); C07K1 / 14 (2006.01); CO7K 14/47 (2006.01)
    Classification of the application according to CPC:
    A61K 38/17 (2013.01); C07K1 / 14 (2013.01); CO7K 14/472 (2013.01)
    Researched test substance (classification):
    A61K, C07K
    Consulted online database:
    WPI, EPODOC, full text
    This research report was published on November 25, 2014
    权利要求:
    Claims (2)
    [1]
    Claims 1-23 created, rm
    Category*·
    Title of the publication:
    Country code, publication number, document type (applicant), publication date, text or figure if necessary
    Concerning
    claim
    A
    A
    US 2008318841 Al (CHTOUROU ABDESSADAR SAMI [FR], MAZURIER CLAUDINE [FR], POULLE MICHEL [FR], CAUVIN BERNADETTE [FR], DHAINAULT FREDERIC [FR]) December 25, 2008 (December 25, 2008)
    Paragraphs [0100]; Claims 10-16
    WO 2007038995 Al (ZLB BEHRING GMBH [DE], GRONSKI PETER [DE], LICHT CHRISTOPH [DE], HOPPE BERND [DE], ZIPFEL PETER [DE], SKERKA CHRISTINE [DE]) April 12, 2007 (April 12, 2007)
    Page 14, lines 19-22
    1, 2, 4-23
    1, 2, 4-23
    Date of completion of the research: ς t 1 1 examiner:
    [2]
    10/20/2017 1 of 1 MOSSER Reinhold
    *) Categories of the listed documents: A Publication that defines the general state of the art.
    X Publication of particular importance: the application P document which is of importance (categories X or Y), but according to the subject cannot be published as new or on the priority date of the application simply because of this publication.
    inventive activity can be considered based. E Document of particular importance (Category X) from which
    Y Publication of importance: the subject of the application cannot be an “older right” (earlier filing date, however, should be considered as based on inventive step, if the republished, protection is possible in Austria, novelty would be considered)
    Make publication with one or more other publications).
    is associated with this category and this connection for & publication which is a member of the same patent family.
    is obvious to a specialist.
    1/1
    DVR 0078018
    类似技术:
    公开号 | 公开日 | 专利标题
    AT514675A3|2018-05-15|PREPARATION OF FACTOR H | AND FH DERIVATIVES FROM PLASMA
    Chen et al.2017|A systematic review of the survival and complication rates of inlay-retained fixed dental prostheses
    Poggio et al.2015|Cleaning effectiveness of three NiTi rotary instruments: a focus on biomaterial properties
    Centers for Disease Control and Prevention (CDC2011|Dental caries in rural Alaska Native children--Alaska, 2008
    Chrcanovic et al.2020|Dental implants in patients with oral lichen planus: A systematic review
    Alqarawi et al.2021|Influence of different conditioning treatments on the bond integrity of root dentin to rGO infiltrated dentin adhesive. SEM, EDX, FTIR and microRaman study
    Herman et al.2021|In Vitro Assessment of Long-Term Fluoride Ion Release from Nanofluorapatite
    AT513369A3|2018-08-15|Method for generating, transmitting and receiving stereoscopic images, and associated apparatus
    Shetty et al.2017|Alkaline material effects on roots of teeth
    Sarapultseva et al.2019|Flowable bulk-fill materials compared to nano ceramic composites for class I cavities restorations in primary molars: A two-year prospective case-control study
    Palczewska-Komsa et al.2021|New Bioactive Calcium Silicate Cement Mineral Trioxide Aggregate Repair High Plasticity |—A Systematic Review
    Centers for Medicare & Medicaid Services |, HHS2014|Medicare and Medicaid programs; CY 2015 Home Health Prospective Payment System rate update; Home Health Quality Reporting Requirements; and survey and enforcement requirements for home health agencies. Final rule
    DE102011005872A1|2012-09-27|Process for the production and further processing of dental prostheses
    Szczesio-Wlodarczyk et al.2019|The Influence of Aging in Solvents on Dental Cements Hardness and Diametral Tensile Strength
    Serra-Pastor et al.2021|Periodontal behavior and patient satisfaction of anterior teeth restored with single zirconia crowns using a biologically oriented preparation technique: A 6-year prospective clinical study
    AT518469A3|2018-01-15|Seal and window element
    AT517179A3|2018-03-15|Device for fastening brake devices to a chassis frame of a rail vehicle
    Reda et al.2022|Applications and Clinical Behavior of BioHPP in Prosthetic Dentistry: A Short Review
    Lim et al.2020|A new method of measuring the volumetric change of alveolar bone around dental implants using computed tomography
    Mickenautsch2017|What is the recent evidence that merit composite resin for direct tooth restorations |?[November 18, 2016]
    Alzanbaqi et al.2022|Zirconia Crowns for Primary Teeth: A Systematic Review and Meta-Analyses
    Mickenautsch2019|Clinical merits of restorative treatment of root | caries lesions [November 13, 2017]
    Jocham et al.2007|FROM THE EDITORS| Medical Laser Application-Volume 22, Issue 1
    Mickenautsch2020|Clinical merits of restorative treatment of root | caries lesions [November 5, 2018]
    Mickenautsch2019|What is the clinical merit of bioactive glass in restorative dentistry?[November 28, 2017]
    同族专利:
    公开号 | 公开日
    US9109044B2|2015-08-18|
    AT516600A5|2016-07-15|
    AT514675A2|2015-02-15|
    US8304524B2|2012-11-06|
    US20130102537A1|2013-04-25|
    AT516600B1|2016-07-15|
    AT514675B1|2019-05-15|
    US20130303731A1|2013-11-14|
    US8822656B2|2014-09-02|
    US20110021432A1|2011-01-27|
    WO2011011753A1|2011-01-27|
    引用文献:
    公开号 | 申请日 | 公开日 | 申请人 | 专利标题
    WO2007038995A1|2005-09-19|2007-04-12|Csl Behring Gmbh|Factor h for the treatment of chronic nephropathies and production thereof|
    US20080318841A1|2005-12-07|2008-12-25|Laboratoire Francais Du Fractionnement Et Des Biotechnologies S.A.|Method For Preparing a Factor H Concentrate and the Use Thereof in the Form of a Drug|
    US4136094A|1977-08-31|1979-01-23|The Regents Of The University Of Minnesota|Preparation of intravenous human and animal gamma globulins and isolation of albumin|
    DK166763B1|1983-03-16|1993-07-12|Immuno Ag|IMMUNOGLOBULIN-G-CONTAINING FRACTION|
    JPH0742235B2|1985-11-08|1995-05-10|三共株式会社|Prophylactic / therapeutic agent for autoimmune diseases|
    US5177194A|1990-02-01|1993-01-05|Baxter International, Inc.|Process for purifying immune serum globulins|
    AU775149B2|1999-10-21|2004-07-22|Alcon Inc.|Sub-tenon drug delivery|
    NZ608860A|2005-02-14|2014-10-31|Univ Iowa Res Found|Methods and reagents for treatment and diagnosis of age-related macular degeneration|
    ES2595059T3|2007-03-20|2016-12-27|Csl Behring Gmbh|Methods for the industrial scale production of therapeutic preparations of complement factor H from human plasma|US8623395B2|2010-01-29|2014-01-07|Forsight Vision4, Inc.|Implantable therapeutic device|
    WO2010088548A1|2009-01-29|2010-08-05|Forsight Labs, Llc|Posterior segment drug delivery|
    US8772462B2|2010-05-26|2014-07-08|Baxter International Inc.|Removal of serine proteases by treatment with finely divided silicon dioxide|
    US8796430B2|2010-05-26|2014-08-05|Baxter International Inc.|Method to produce an immunoglobulin preparation with improved yield|
    AU2010202125B1|2010-05-26|2010-09-02|Takeda Pharmaceutical Company Limited|A method to produce an immunoglobulin preparation with improved yield|
    BR112013001753A2|2010-07-23|2016-05-31|Baxter Healthcare Sa|a method for preparing a plasma erected alpha-inhibitorcomposition, aqueous iaip solution, and a method for treating a disease or disorder associated with iaip dysfunction and associated with increased plasma serine protease activity.|
    LT2600812T|2010-08-05|2021-11-10|Forsight Vision4, Inc.|Apparatus to treat an eye|
    IL212911D0|2011-05-16|2011-07-31|Omrix Biopharmaceuticals Ltd|Immunoglobulin reduced in thrombogenic contaminants and preparation thereof|
    TWI629283B|2012-02-23|2018-07-11|巴克斯歐塔公司|Fraction i-iv-1 precipitation of immunoglobins from plasma|
    AU2014236782B2|2013-03-14|2019-01-03|Baxalta GmbH|Factor H for treatment of rheumatoid arthritis|
    HUE039464T2|2013-03-14|2019-01-28|Baxalta Inc|Factor h for transplantation|
    AU2013202965B2|2013-03-15|2016-07-21|Takeda Pharmaceutical Company Limited|Improved method for producing factor h from a plasma precipitation fraction|
    AU2013203048A1|2013-03-15|2014-10-02|Baxalta GmbH|Isolation of factor h from fraction i paste|
    CN105246438B|2013-03-28|2018-01-26|弗赛特影像4股份有限公司|For conveying the ophthalmic implant of therapeutic substance|
    CN108495860A|2015-09-29|2018-09-04|K·黄|A method of preparing intravenous injection of immunoglobulin from component III|
    WO2017062536A2|2015-10-06|2017-04-13|Kieu Hoang|A method of manfacturing prothrombin complex concentrate from fraction iii and non-prothrombin complex concentrate from fraction iv|
    EA201990257A1|2016-10-24|2019-07-31|Алкахест, Инк.|BLOOD PLASMA FRACTIONS AS A TREATMENT OF COGNITIVE DISORDERS RELATED TO AGING|
    US11103530B2|2018-10-26|2021-08-31|Alkahest, Inc.|Methods of improving or accelerating postoperative recovery|
    法律状态:
    2021-09-15| PC| Change of the owner|Owner name: TAKEDA PHARMACEUTICAL COMPANY LIMITED, JP Effective date: 20210719 |
    优先权:
    申请号 | 申请日 | 专利标题
    US22796809P| true| 2009-07-23|2009-07-23|
    [返回顶部]